Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma
- 1 September 2015
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 135 (9), 2328-2331
- https://doi.org/10.1038/jid.2015.163
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous MelanomaJournal of Investigative Dermatology, 2015
- Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanomaPigment Cell & Melanoma Research, 2013
- Epigenetic disruption of cadherin‐11 in human cancer metastasisThe Journal of Pathology, 2012
- Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cellsOncogene, 2011
- Myopodin Methylation is Associated With Clinical Outcome in Patients With T1G3 Bladder CancerJournal of Urology, 2010
- Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free SurvivalClinical Cancer Research, 2009
- Multiple isoforms of the tumor suppressor myopodin are simultaneously transcribed in cancer cellsBiochemical and Biophysical Research Communications, 2008
- Myopodin-Mediated Suppression of Prostate Cancer Cell Migration Involves Interaction with ZyxinCancer Research, 2006
- Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical OutcomeJNCI Journal of the National Cancer Institute, 2006
- Myopodin, a Synaptopodin Homologue, Is Frequently Deleted in Invasive Prostate CancersThe American Journal of Pathology, 2001